Healthcare & Life Sciences
Telios Pharma
United States
series-a
series-a
Stage
1
Investors
About
Telios Pharma is a biopharmaceutical company developing therapeutics aimed at fibrotic diseases and cancer by targeting fundamental pathways involved in tissue fibrosis and tumor progression.
Explore Telios Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.